Intranasally administered Lactobacillus gasseri TMC0356 protects mice from H1N1 influenza virus infection by stimulating respiratory immune responses
Authors:
- 25 June 2010
- journal article
- Published by Springer Nature in World Journal of Microbiology and Biotechnology
- Vol. 27 (2) , 411-416
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Effect of fermented milk prepared with two probiotic strains on Japanese cedar pollinosis in a double-blind placebo-controlled clinical studyInternational Journal of Food Microbiology, 2009
- Seasonal inactivated influenza virus vaccinesVaccine, 2008
- Clinical Indications for Probiotics: An OverviewClinical Infectious Diseases, 2008
- Synergistic effect of intratumoral IL-12 and TNF-α microspheres: systemic anti-tumor immunity is mediated by both CD8+ CTL and NK cellsSurgery, 2007
- Essential Roles of Monocytes in Stimulating Human Peripheral Blood Mononuclear Cells with Lactobacillus casei To Produce Cytokines and Augment Natural Killer Cell ActivityClinical and Vaccine Immunology, 2006
- Interleukin-12 is involved in the enhancement of human natural killer cell activity byLactobacillus caseiShirotaClinical and Experimental Immunology, 2006
- Reduction of Influenza Virus Titer and Protection against Influenza Virus Infection in Infant Mice FedLactobacillus caseiShirotaClinical and Vaccine Immunology, 2004
- Effect of Intranasal Administration ofLactobacillus caseiShirota on Influenza Virus Infection of Upper Respiratory Tract in MiceClinical and Diagnostic Laboratory Immunology, 2001
- Lactic acid bacterium potently induces the production of interleukin-12 and interferon-γ by mouse splenocytesInternational Journal of Immunopharmacology, 1999
- Induction of natural killer cell migration by monocyte chemotactic protein−1, −2 and −3European Journal of Immunology, 1994